Streetbeat News

Products Services

TLRY

Tilray has renewed its distribution agreement with Great North Distributors, Inc. for cannabis sales across Canada. This will continue to facilitate Tilray's product distribution and reach in the Canadian market.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 11:07 am

CKPT

Checkpoint Therapeutics has announced longer-term data showing increases in complete response rates for its drug, Cosibelimab, in advanced cutaneous squamous cell carcinoma. The drug demonstrated a 55% objective response rate and a 23% complete response rate in locally advanced cSCC, and a 50% objective response rate and a 13% complete response rate in metastatic cSCC. The drug continues to show a favorable safety profile and its Biologics License Application is currently under review by the U.S. FDA, with a PDUFA goal date of January 3, 2024.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 11:05 am

STLA

Stellantis NV's CEO, Carlos Tavares, revealed during the company's Q2 earnings call that they benchmark their performance against Tesla and Korean automakers. Stellantis recently unveiled the STLA Medium, the first of four BEV platforms, which can produce up to 2 million vehicles per year. The company aims to become carbon net zero by 2038 and sees annual BEV sales reaching 5 million by 2030. For H1, Stellantis reported net revenues of €98.4 billion ($109.5 billion), up 12% YoY, and a 37% increase in net profit to €10.9 billion.

Portfolio Pulse from Anan Ashraf

July 27, 2023 | 11:01 am

META

Meta Platforms Inc. (NASDAQ:META) reported a significant increase in revenue from $3 billion to $10 billion, largely driven by the success of Facebook and Instagram Reels. The company's AI investments have played a crucial role in this growth, with AI-recommended content becoming the fastest-growing category on Facebook's feed. The introduction of these AI-powered recommendations has resulted in a 7% increase in overall time users spend on the platform.

Portfolio Pulse from Ananya Gairola

July 27, 2023 | 10:58 am

TSCO

Tractor Supply Company (TSCO) has announced a new long-term target of 3,000 stores in the US, with plans to increase annual new store openings to 90 per year.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 10:57 am

LLY

Eli Lilly has announced the successful results of two Phase 3 studies for Tirzepatide in adults with obesity and weight-related comorbidities, excluding Type 2 diabetes. The studies, SURMOUNT-3 and SURMOUNT-4, met all primary and key secondary objectives compared to placebo.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 10:51 am

LPCN

Lipocine Inc. reported that its LPCN 1148 Phase 2 Study met its primary endpoint in patients with cirrhosis, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 10:49 am

MRK

Merck has announced positive topline results from two Phase 3 trials of V116, an investigational 21-valent pneumococcal conjugate vaccine. The trials demonstrated immune responses in both vaccine-naïve and vaccine-experienced adult patient populations.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 10:47 am

GOOG

GOOGL

Google, a subsidiary of Alphabet Inc., has updated its Play Store guidelines and ranking algorithms to prioritize apps and games optimized for large screens. Apps not optimized for large screens or with high crash rates will be downranked. This move is likely motivated by Google's focus on tablets and large-screen devices, including the new Pixel Tablet and Pixel Fold.

Portfolio Pulse from Rounak Jain

July 27, 2023 | 10:40 am

LPCN

Lipocine Inc. has announced positive topline results from a Phase 2 study of LPCN 1148, a drug for the clinical management of cirrhosis. The study met its primary endpoint, showing that treatment with LPCN 1148 increased the L3 skeletal muscle index relative to placebo.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 10:35 am